An economic evaluation of first-line cryoballoon ablation vs antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a U.S. Medicare perspective

BACKGROUND: Three recent randomized controlled trials have demonstrated that, as an initial rhythm control strategy, first-line cryoballoon ablation (cryoablation) reduces atrial arrhythmia recurrence compared with antiarrhythmic drugs (AADs) in patients with symptomatic paroxysmal atrial fibrillati...

Descripción completa

Detalles Bibliográficos
Autores principales: Wazni, Oussama, Moss, Joe, Kuniss, Malte, Andrade, Jason, Chierchia, Gian Battista, Mealing, Stuart, Mburu, Waruiru, Sale, Alicia, Kaplon, Rachelle, Ismyrloglou, Eleni, Bromilow, Tom, Lane, Emily, Lewis, Damian, Reynolds, Matthew R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513914/
https://www.ncbi.nlm.nih.gov/pubmed/37744940
http://dx.doi.org/10.1016/j.hroo.2023.07.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513914/
https://www.ncbi.nlm.nih.gov/pubmed/37744940
http://dx.doi.org/10.1016/j.hroo.2023.07.007

Ejemplares similares